Injectable cabotegravir and rilpivirine should not be used with: the anticonvulsants carbamazepine, oxcarbazepine, phenobarbital, phenytoin the antimycobacterials rifabutin, rifampicin, rifapentine ...
The WHO says that 490,000 people have multidrug-resistant tuberculosis (MDR-TB), when bacteria do not respond to the two most powerful first-line anti-TB drugs, isoniazid and rifampicin.
Brucellosis is a global public health concern and occurs mainly in young adults and the elderly, with children having a lower incidence, thus often leading to delayed treatment. This study aimed to ...